Noradrenalin Sintetica (Noradrenaline Tartrate)

Norepinephrine, the active ingredient in Noradrenalin Sintetica, is a sympathomimetic vasopressor presented as an injectable solution for intravenous use. It is employed in critical care to rapidly increase arterial pressure in patients experiencing acute hypotension, septic shock, or cardiogenic shock, thereby supporting vital organ perfusion.

GNH USA supplies Noradrenalin Sintetica as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide under strict quality standards. The company ensures consistent batch release and regulatory compliance across EU markets.

Noradrenaline (norepinephrine) is a potent vasopressor employed in critical care to counteract severe drops in blood pressure associated with various shock states.

Acute hypotension: restores arterial pressure to maintain organ perfusion and prevent ischemic injury. Septic shock: reestablishes vascular tone, improves hemodynamic stability, and supports vital organ function during severe infection. Cardiogenic shock: supports circulatory pressure and systemic perfusion when cardiac output is insufficient, aiding recovery in heart‑failure emergencies. Postoperative hypotension: provides rapid blood pressure support after major surgery, helping to stabilize patients in the immediate recovery period.

Norepinephrine may be associated with several adverse reactions, ranging from common to serious.

Common Side Effects: - Tachycardia: increased heart rate often observed during infusion. - Hypertension: elevated blood pressure beyond therapeutic target. - Headache: mild to moderate headache may occur. - Arrhythmia: irregular heart rhythm may develop. - Nausea: feeling of sickness may be reported.

Serious or Rare Side Effects: - Cardiac arrest: sudden loss of cardiac activity, requiring immediate resuscitation. - Tissue necrosis at infusion site: severe local ischemia leading to skin breakdown. - Myocardial ischemia: reduced coronary blood flow causing chest pain or infarction.

When using norepinephrine, careful clinical monitoring and specific precautions are required to ensure patient safety.

Dose titration: adjust infusion rate to achieve target mean arterial pressure. Monitoring: continuous hemodynamic and cardiac rhythm monitoring is essential. Contraindications: avoid use in patients with uncorrected hypovolemia. Drug interactions: be cautious when co‑administered with MAO inhibitors or tricyclic antidepressants. Pregnancy and lactation: use only if potential benefit justifies potential risk to fetus or infant. Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Norepinephrine can interact with several medications, altering its efficacy or safety profile.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis due to excessive catecholamine activity. - Tricyclic antidepressants: additive vasoconstriction may cause severe hypertension. - Beta‑blockers: may blunt the desired cardiac response to norepinephrine.

Moderate Interactions (Monitor Closely): - Vasodilators (e.g., nitroglycerin): may require higher norepinephrine doses to maintain pressure. - Calcium channel blockers: potential additive cardiovascular effects necessitate monitoring. - Diuretics: can exacerbate hypovolemia, increasing risk of inadequate response.